Skip to content
Catalyst

rosuvastatinPapers

Returned by a PubMed search for rosuvastatin

papers
646
26 years, by papers

Newest first

1 to 50 of 646
  • Bioequivalence and safety of fixed-dose combination of rosuvastatin calcium and ezetimibe tablets versus coadministration of individual drugs in healthy Chinese subjects under fasting or fed state.

    Naunyn-Schmiedeberg's archives of pharmacology2026PMID 40719894

  • Efficacy and safety of switching to ezetimibe 10 mg/rosuvastatin 2.5 mg in Korean patients with type 2 diabetes mellitus and dyslipidaemia: A multicentre, prospective study (EROICA study).

    Diabetes, obesity & metabolism2026PMID 41190361

  • HMGCR and Rosuvastatin Regulates GLP-1 Secretion and Expression-A Translational Study.

    The Journal of clinical endocrinology and metabolism2026PMID 41206007

  • The efficacy of preoperative evolocumab-rosuvastatin combination therapy in patients with ST-elevation myocardial infarction.

    PloS one2026PMID 41481564Also tests rosuvastatin

  • Pharmacokinetic comparison of ezetimibe/rosuvastatin/telmisartan 10/20/80 mg fixed-dose combination versus coadministration of separate tablets in healthy participants.

    Naunyn-Schmiedeberg's archives of pharmacology2026PMID 41504880Also tests rosuvastatin

  • Rosuvastatin calcium administration and its impact on myocardial microcirculation and postoperative recovery in patients undergoing coronary artery bypass grafting.

    Journal of cardiothoracic surgery2026PMID 42237405

  • Locally delivered simvastatin and rosuvastatin in the treatment of chronic periodontitis: A systematic review and meta-analysis.

    American journal of dentistry2026PMID 42247362

  • Dose-dependent effects of rosuvastatin in deep vein thrombosis: a retrospective cohort study.

    International angiology2026PMID 42294986

  • The effect of hypoprolactinemia on cardiometabolic effects of rosuvastatin in men: A matched Cohort Pilot Study.

    Pituitary2026PMID 42384084

  • Short-term efficacy of moderate-intensity rosuvastatin in coronavirus disease 2019 patients: A randomized clinical trial.

    Journal of investigative medicine2025PMID 39205322

  • Pharmacokinetic Drug-Drug Interaction between Cilostazol and Rosuvastatin in Healthy Participants.

    American journal of cardiovascular drugs2025PMID 39487337

  • Triple Therapy with Telmisartan, Amlodipine, and Rosuvastatin (TAR) Versus Telmisartan/Amlodipine (TA) and Telmisartan/Rosuvastatin (TR) Combinations in Hypertension and Dyslipidemia: A Systematic Review and Meta-analysis.

    High blood pressure & cardiovascular prevention2025PMID 39557773

  • Neurodevelopmental and Growth Follow-Up of an Infant Exposed to Rosuvastatin by Lactation: A Case Report.

    Breastfeeding medicine2025PMID 39866136

  • Pharmacokinetic comparison of a fixed-dose combination of telmisartan/rosuvastatin/ezetimibe/amlodipine 80/20/10/5 mg and a loose-dose combination of ezetimibe/rosuvastatin 10/20 mg and telmisartan/amlodipine 80/5 mg in healthy male subjects.

    Naunyn-Schmiedeberg's archives of pharmacology2025PMID 39907783

  • Effect of ABCG2 c.421 C> A (rs2231142) single nucleotide polymorphisms on the lipid-modulating efficacy of rosuvastatin: a meta-analysis.

    BMC cardiovascular disorders2025PMID 40082758Also tests rosuvastatin

  • Comparison of rosuvastatin 10 mg plus ezetimibe versus rosuvastatin 20 mg in atherosclerotic cardiovascular disease and type 2 diabetes.

    Scientific reports2025PMID 40341101

  • Population Pharmacokinetics and Pharmacodynamics with Enterohepatic Recirculation of Co-Medication of Rosuvastatin and Ezetimibe.

    Drug design, development and therapy2025PMID 40491527

  • A Systematic Review and Meta-Analysis on the Safety and Efficacy of Rosuvastatin as an Adjunctive Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

    International journal of chronic obstructive pulmonary disease2025PMID 40529224Also tests rosuvastatin

  • Multiply doses of FDC of rosuvastatin and ezetimibe versus rosuvastatin monotherapy in Chinese patients with hypercholesterolemia (ROSE-CH): multicenter, randomized-controlled trial.

    Lipids in health and disease2025PMID 40696391

  • The pharmacogenetics of rosuvastatin and implications for treatment: a systematic review.

    Pharmacogenomics2025PMID 40838969

  • A randomized controlled trial of the short-term effect of rosuvastatin on the corrected QT interval.

    Scientific reports2025PMID 40890448Also tests rosuvastatin

  • Effectiveness and Safety of Very-Low-Dose Rosuvastatin-Ezetimibe Therapy in Korean Patients with Dyslipidaemia: A Multicentre Prospective Observational Study.

    Clinical drug investigation2025PMID 40956520

  • Rosuvastatin for Improving Fetal Growth Restriction in Pregnant Women: A Double-Blind Randomized Clinical Trial.

    Iranian journal of medical sciences2025PMID 40977961

  • Efficacy and Safety of Rosuvastatin/Amlodipine FDC in Patients With Hypertension and Dyslipidemia: A Multicenter, Prospective, Observational Study.

    Clinical therapeutics2025PMID 41073206

  • Switching to rosuvastatin plus ezetimibe in statin-treated stroke patients with low-density lipoprotein cholesterol levels above 70 mg/dL (SWITCH): a prospective observational study.

    Lipids in health and disease2025PMID 41225467

  • The potential effects of cinnamon, cumin, and Rosuvastatin on lipid profile among Iraqi patients with dyslipidemia.

    Wiadomosci lekarskie (Warsaw, Poland2025PMID 41401318

  • Ticagrelor Increases Exposure to the Breast Cancer Resistance Protein Substrate Rosuvastatin.

    Clinical pharmacology and therapeutics2024PMID 37786998

  • Influence of the rs4238001 Genetic Polymorphism of the SR-B1 Gene on Serum Lipid Levels and Response to Rosuvastatin in Myocardial Infarction Iraqi Patients.

    Biochemical genetics2024PMID 38133857

  • Moderate-Intensity Rosuvastatin/Ezetimibe Combination versus Quadruple-Dose Rosuvastatin Monotherapy: A Meta-Analysis and Systemic Review.

    Yonsei medical journal2024PMID 38154476

  • Comparative Efficacy of Rosuvastatin Monotherapy and Rosuvastatin/Ezetimibe Combination Therapy on Insulin Sensitivity and Vascular Inflammatory Response in Patients with Type 2 Diabetes Mellitus.

    Diabetes & metabolism journal2024PMID 38173371

  • Efficacy of Dyslipidemia Control by Combination Therapy with Rosuvastatin 10 Mg and Ezetimibe 10 Mg Compared with Rosuvastatin 20 Mg Monotherapy in Patients with Chronic Coronary Syndromes: A Randomized, Single-blind Controlled Trial.

    Cardiovascular & hematological agents in medicinal chemistry2024PMID 38275031

  • Efficacy and safety of combination therapy with telmisartan, rosuvastatin, and ezetimibe in patients with dyslipidemia and hypertension: A randomized, double-blind, multicenter, therapeutic confirmatory, phase III clinical trial.

    Journal of clinical hypertension (Greenwich, Conn.)2024PMID 38319595

  • Distinct effects of rosuvastatin and rosuvastatin/ezetimibe on senescence markers of CD8+ T cells in patients with type 2 diabetes mellitus: a randomized controlled trial.

    Frontiers in endocrinology2024PMID 38586464

  • Amelioration of gait and balance disorders by rosuvastatin is associated with changes in cerebrovascular reactivity in older patients with hypertensive treatment.

    Hypertension research2024PMID 38769134

  • Pharmacokinetics of a Fixed-Dose Combination Product of Amlodipine, Losartan, Ezetimibe, and Rosuvastatin and Its Comparison with Co-administration of Four Individual Components in Healthy Participants.

    Drugs in R&D2024PMID 38775910

  • Rosuvastatin attenuates total-tau serum levels and increases expression of miR-124-3p in dyslipidemic Alzheimer's patients: a historic cohort study.

    Metabolic brain disease2024PMID 38896205

  • Differential Adherence to Free and Single-Pill Combination of Rosuvastatin/Ezetimibe: Findings from a Real-World Analysis in Italy.

    Advances in therapy2024PMID 38963586

  • Possible protective effect of rosuvastatin in chemotherapy-induced cardiotoxicity in HER2 positive breast cancer patients: a randomized controlled trial.

    Medical oncology (Northwood, London, England)2024PMID 38977536

  • Effects of rosuvastatin on serum asymmetric dimethylarginine levels and incidence of long-term cardiovascular events in patients with hyperlipidaemia and H-type hypertension.

    British journal of hospital medicine (London, England2024PMID 39078896

  • Impact of rosuvastatin on pulse-wave velocity in men with HIV at moderate cardiovascular risk.

    AIDS (London, England)2024PMID 39088829

  • Assessing the effect of high-dose rosuvastatin in elderly patients over 75 with acute coronary syndrome.

    BMC cardiovascular disorders2024PMID 39243009

  • Impact of rosuvastatin on metabolic syndrome patients with moderate to severe metabolic associated fatty liver disease without overt diabetes: A randomized clinical trial.

    Diabetes & metabolic syndrome2024PMID 39326342

  • Efficacy and safety of moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin monotherapy in the treatment of composite cardiovascular events with hypercholesterolemia: A meta-analysis.

    PloS one2024PMID 39536001

  • Clinical Efficacy of Ezetimibe Combined with Rosuvastatin in the Treatment of Patients with Primary Hypercholesterolemia Inadequately Controlled by Statin Therapy.

    British journal of hospital medicine (London, England2024PMID 39618211

  • PET-CT outcomes from a randomised controlled trial of rosuvastatin as an adjunct to standard tuberculosis treatment.

    Nature communications2024PMID 39622823

  • Comparative Effects of Low-Dose Rosuvastatin, Placebo, and Dietary Supplements on Lipids and Inflammatory Biomarkers.

    Journal of the American College of Cardiology2023PMID 36351465

  • Pharmacokinetic Interactions and Tolerability of Rosuvastatin and Ezetimibe: A Randomized, Phase 1, Crossover Study in Healthy Chinese Participants.

    European journal of drug metabolism and pharmacokinetics2023PMID 36437383

  • Colchicine and high-intensity rosuvastatin in the treatment of non-critically ill patients hospitalised with COVID-19: a randomised clinical trial.

    BMJ open2023PMID 36828654

  • A Bioequivalence Study of Ezetimibe/Rosuvastatin Fixed Dose Combination (10 mg/10 mg) Versus the Individual Formulations Taken Concomitantly.

    Advances in therapy2023PMID 36897521

  • Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trial.

    The Lancet. Infectious diseases2023PMID 36966799

The next 50 papers

Every paper about rosuvastatin